Combating poor-quality anti-malarial medicines: a call to action

The circulation of poor-quality medicines continues to undermine the fight against many life-threatening diseases. Anti-malarial medicines appear to have been particularly compromised and present a major public health threat in malaria-endemic countries, negatively affecting individuals and their co...

Descripción completa

Detalles Bibliográficos
Autores: Bassat Orellana, Quique, Tanner, Marcel, Guerin, Philippe J., Stricker, Kirstin, Hamed, Kamal
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/99590
Acceso en línea:https://hdl.handle.net/2445/99590
Access Level:acceso abierto
Palabra clave:Malària
Vacuna de la malària
Malaria
Malaria vaccine
id ES_0d56ec44f2c0a3cc9932cf6a2cfc40c5
oai_identifier_str oai:diposit.ub.edu:2445/99590
network_acronym_str ES
network_name_str España
repository_id_str
spelling Combating poor-quality anti-malarial medicines: a call to actionBassat Orellana, QuiqueTanner, MarcelGuerin, Philippe J.Stricker, KirstinHamed, KamalMalàriaVacuna de la malàriaMalariaMalaria vaccineThe circulation of poor-quality medicines continues to undermine the fight against many life-threatening diseases. Anti-malarial medicines appear to have been particularly compromised and present a major public health threat in malaria-endemic countries, negatively affecting individuals and their communities. Concerted collaborative efforts are required from global, regional and national organizations, involving the public and private sectors, to address the problem. While many initiatives are underway, a number of unmet needs deserve urgent and increased multisector attention. At the global level, there is a need for an international public health legal framework or treaty on poor-quality medicines, with statutes suitable for integration into national laws. In addition, increased international efforts are required to strengthen the governance of global supply chains and enhance cooperation between national medicine regulation authorities and law enforcement bodies. Increased investment is needed in innovative technologies that will enable healthcare teams to detect poor-quality medicines at all levels of the supply chain. At the regional level, a number of initiatives would be beneficial-key areas are standardization, simplification, and reciprocal recognition of registration processes and development of quality control capacity in regional centres of excellence that are better aligned with public health needs; improved surveillance methods and creation of a framework for compulsory and transparent reporting of poor-quality medicines; additional support for national medicine regulation authorities and other national partner authorities; and an increase in support for regional laboratories to boost their capabilities in detecting poor-quality medicines. It is vital that all stakeholders involved in efforts against poor-quality anti-malarial medicines extend and strengthen their actions in these critical areas and thus effectively support global health development and malaria elimination programmes.BioMed Central2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/99590Articles publicats en revistes (ISGlobal)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: http://dx.doi.org/10.1186/s12936-016-1357-8Malaria Journal, 2016, vol. 15, num. 302, p. 1-12http://dx.doi.org/10.1186/s12936-016-1357-8cc0 (c) Bassat Orellana et al., 2016http://creativecommons.org/publicdomain/zero/1.0/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/995902026-05-27T06:46:51Z
dc.title.none.fl_str_mv Combating poor-quality anti-malarial medicines: a call to action
title Combating poor-quality anti-malarial medicines: a call to action
spellingShingle Combating poor-quality anti-malarial medicines: a call to action
Bassat Orellana, Quique
Malària
Vacuna de la malària
Malaria
Malaria vaccine
title_short Combating poor-quality anti-malarial medicines: a call to action
title_full Combating poor-quality anti-malarial medicines: a call to action
title_fullStr Combating poor-quality anti-malarial medicines: a call to action
title_full_unstemmed Combating poor-quality anti-malarial medicines: a call to action
title_sort Combating poor-quality anti-malarial medicines: a call to action
dc.creator.none.fl_str_mv Bassat Orellana, Quique
Tanner, Marcel
Guerin, Philippe J.
Stricker, Kirstin
Hamed, Kamal
author Bassat Orellana, Quique
author_facet Bassat Orellana, Quique
Tanner, Marcel
Guerin, Philippe J.
Stricker, Kirstin
Hamed, Kamal
author_role author
author2 Tanner, Marcel
Guerin, Philippe J.
Stricker, Kirstin
Hamed, Kamal
author2_role author
author
author
author
dc.subject.none.fl_str_mv Malària
Vacuna de la malària
Malaria
Malaria vaccine
topic Malària
Vacuna de la malària
Malaria
Malaria vaccine
description The circulation of poor-quality medicines continues to undermine the fight against many life-threatening diseases. Anti-malarial medicines appear to have been particularly compromised and present a major public health threat in malaria-endemic countries, negatively affecting individuals and their communities. Concerted collaborative efforts are required from global, regional and national organizations, involving the public and private sectors, to address the problem. While many initiatives are underway, a number of unmet needs deserve urgent and increased multisector attention. At the global level, there is a need for an international public health legal framework or treaty on poor-quality medicines, with statutes suitable for integration into national laws. In addition, increased international efforts are required to strengthen the governance of global supply chains and enhance cooperation between national medicine regulation authorities and law enforcement bodies. Increased investment is needed in innovative technologies that will enable healthcare teams to detect poor-quality medicines at all levels of the supply chain. At the regional level, a number of initiatives would be beneficial-key areas are standardization, simplification, and reciprocal recognition of registration processes and development of quality control capacity in regional centres of excellence that are better aligned with public health needs; improved surveillance methods and creation of a framework for compulsory and transparent reporting of poor-quality medicines; additional support for national medicine regulation authorities and other national partner authorities; and an increase in support for regional laboratories to boost their capabilities in detecting poor-quality medicines. It is vital that all stakeholders involved in efforts against poor-quality anti-malarial medicines extend and strengthen their actions in these critical areas and thus effectively support global health development and malaria elimination programmes.
publishDate 2016
dc.date.none.fl_str_mv 2016
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/99590
url https://hdl.handle.net/2445/99590
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: http://dx.doi.org/10.1186/s12936-016-1357-8
Malaria Journal, 2016, vol. 15, num. 302, p. 1-12
http://dx.doi.org/10.1186/s12936-016-1357-8
dc.rights.none.fl_str_mv cc0 (c) Bassat Orellana et al., 2016
http://creativecommons.org/publicdomain/zero/1.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc0 (c) Bassat Orellana et al., 2016
http://creativecommons.org/publicdomain/zero/1.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv Articles publicats en revistes (ISGlobal)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403334411026432
score 15,301603

Similares en LA Referencia